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The Human Microbiome Project
(HMP) [1,2] is a concept that was long
in the making. After the Human Ge-
nome Project, interest grew in sequenc-
ing the ‘‘other genome’’ of microbes
carried in and on the human body
[3,4]. Microbial ecologists, realizing that
.99% of environmental microbes could
not be easily cultured, developed ap-
proaches to study microorganisms in situ
[5], primarily by sequencing the 16S
r i b o s o m a lR N Ag e n e( 1 6 S )a sap h y l o -
genetic and taxonomic marker to identify
members of microbial communities [6].
The need to develop corresponding new
methods for culture-independent studies
[7,8] in turn precipitated a sea change in
the study of microbes and human health,
inspiring the new term ‘‘metagenomics’’
[9] both to describe a technological
approach—sequencing and analysis of
the genes from whole communities rath-
er than from individual genomes—and
to emphasize that microbes function
within communities rather than as indi-
vidual species. This shift from a focus on
individual organisms to microbial inter-
actions [10] culminated in a National
Academy of Science report [11], which
outlined challenges and promises for
metagenomics as a way of understanding
the foundational role of microbial com-
munities both in the environment and in
human health.
Pioneering medical microbiologists
applied these approaches, finding far
more microbial diversity than expected
even in well-studied body site habitats
[12]. Technological advances further
enabled sequencing of communities
across the human body, and immunolo-
gists began exploring the fundamental
role of microorganisms in the maturation
o ft h ei n n a t ea n da d a p t i v ei m m u n e
systems. Initial metagenomic studies of
human-associated microbial communi-
ties were performed using the traditional
Sanger platform [13,14]. Upon intro-
duction of pyrosequencing [15], the
number of 16S-based data sets increased
dramatically [16,17]. The time was right
to invest in a concerted study of the
microbial communities associated with
the human body and the metabolic
capabilities they provide—the human
microbiome (Figure 1) [18].
To coordinate these efforts relating the
microbiome to human health, the NIH
Common Fund launched the HMP as a
community resource program (http://
commonfund.nih.gov/hmp/) [19]. One
of its main goals was to create a baseline
view of the healthy human microbiome
in five major areas (airways, skin, oral
cavity, gastrointestinal tract, and vagina)
and to make this resource available to
the broad scientific community. Charac-
terizing the baseline state of the micro-
biota is a critical first step in determining
how altered microbial states contribute
to disease (e.g., [13,20–23]). Previous
work showed wide inter- and intra-
personal diversity of human-associated
microbes [24], necessitating analysis of a
large number of subjects and character-
ization of many reference bacterial
genomes [25] to assist in interpretation
of metagenomic data. The scope of the
HMP thus required a particularly diverse
consortium (Figure 2A), and collabora-
tion among these teams ultimately stim-
ulated research growth throughout the
field and produced a study including the
first consistent sampling of many clini-
cally relevant body habitats, within a
large population, with paired 16S profil-
ing and deep metagenomic sequencing
coverage for hundreds of microbial
communities.
The HMP required careful consider-
ation of ethical, legal, and social impli-
cations (ELSI) unique to the study of the
microbiome [26]. Such research raises
questions regarding traditional distinc-
tions between self and non-self, human
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ment, and health and disease. The
prospect of manipulating the microbiota
in ways that could permanently alter an
individual’s biological identity requires
the development of new ethical para-
digms analogous to, but not identical to,
those already considered for gene thera-
py. Likewise, just as gene patents have
proven controversial, defining who
‘‘owns’’ a microbiome raises difficult
questions of intellectual property. The
ELSI team helped to develop an appro-
priate sample collection protocol, to draft
a template for informed consent, and
consulted on ethical issues arising during
the study, such as the possibility that
unique human microbiome ‘‘signatures’’
[27] might compromise participant pri-
vacy. A portion of the HMP’s dedicated
research budget continues to be commit-
ted to integrating multidisciplinary ap-
proaches (including philosophical, social
science, and legal methods) to study these
issues and involve stakeholders including
study participants, scientists, policy mak-
ers, patients, and indigenous populations.
Planning for Human
Microbiome Studies: Tools,
Techniques, and Design
Any study of human populations must
put both subject protection and study
design first, and the HMP was no excep-
tion. Power calculations for microbiome
studies in human cohorts are particularly
challenging, as they must simultaneously
address assay types (e.g., 16S versus shot-
gun), depth of sequencing, taxon detection,
and fold abundance changes in clades,
genes, or pathways of interest [28–31].
After study design, as the HMP spanned
multiple sequencing centers over a pro-
longed duration, the group established
standardized and benchmarked protocols
for sample collection [2], handling, and
subsequent 16S profiling [32]. Metage-
nomic library construction was likewise
standardized among centers, and stringent
quality control was aided by the optimiza-
tion of 16S read processing [33] and by
improved taxonomic frameworks for clas-
sification of microbial sequences prior to
biological interpretation [34].
Finally, quality data generation from
appropriately designed microbiome stud-
ies enables a variety of subsequent com-
putational analyses (Figure 2B). While we
refer the reader to existing broader reviews
of human microbiome bioinformatics [35–
37], here we highlight numerous recent
approaches specifically developed during
the HMP. Several of these focused on
microbial interactions, such as ecological
network reconstruction [38,39]. Other
computational methods dealt with meta-
genomic sequences, including both assem-
bly-based [40,41] and assembly-free anal-
yses of microbial community membership
[42] and metabolic function [43]. Both
data types enable taxonomic and phylo-
genetic profiling [44,45], and ecological
metrics proved to associate microbial,
gene, and pathway diversity on an un-
precedented scale [2]. The HMP Data
Analysis Coordination Center (DACC,
http://hmpdacc.org) hosts all available
HMP data and many tools, focusing the
tremendous quantity of raw data through
lenses such as SitePainter [46]; IMG/
HMP, an HMP-specific version of the
Figure 1. Timeline of microbial community studies using high-throughput sequencing. Each circle represents a high-throughput
sequence-based 16S or shotgun metagenomic bioproject in NCBI (May 2012), indicating the amount of sequence data produced for each project
(circle area and y-coordinate) at the time of publication/registration (x-coordinate). Projects are grouped by human-associated (red), other animal
(black), or environmental (green) communities, and shotgun metagenomic projects are marked with a grey band. Selected representative projects are
labeled: open ocean [68], deep sea [69], lean mouse [70], diarrheal illness [71], costal ocean [72], lean/obese gut [53], human microbiome [56],
MetaHIT (gut) [58], cow rumen [73], soil (NCBI BioProject PRJNA50473), and human gut [74]. Note that HMP has deposited a total of 7.44 terabases of
shotgun data in SRA, of which 49% is host DNA derived data that was filtered and only available through protected access in dbGaP project
phs000228.
doi:10.1371/journal.pbio.1001377.g001
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system; METAREP [48]; and MG-RAST
[49], and efforts are ongoing to provide
these data for meta-analysis alongside
other human microbiome studies in the
cloud.
Community Structure, Function,
and a ‘‘Core’’ Human
Microbiome
The HMP was designed in part to
address a key question about our microbial
selves: do all humans have an identifiable
‘‘core’’ microbiome of shared components
comparable to our shared genome [50]?
Several definitions of ‘‘core’’ have been
proposed, recently unified in one concep-
tual framework [51]. Earlier studies re-
ported that different people shared few
microbes in their gut and skin microbiota
[17,52–56], a greater fraction of their oral
microbiota [56,57], or might be classifi-
able into multiple core microbiomes based
on vaginal [20] and gut communities [58].
The HMP provides a comprehensive
picture of the human microbiome cover-
ing multiple body sites and thus an in-
depth exploration of these concepts. The
study confirmed high inter-individual var-
iation [59] and showed that even rare
organisms in these communities are im-
portant reservoirs of genetic diversity [60].
Additionally, the large HMP cohort shows
that the composition of the gut micro-
biome rarely clusters subjects into discrete
types, as was suggested before on more
limited data [61]; although other habitats
such as the vagina can exhibit such
clustering [20], the gut was most often
characterized by smooth abundance gra-
dients of key organisms [2].
A potentially more universal ‘‘core’’
human microbiome emerged during the
consideration of microbial genes and
pathways carried throughout communi-
ties’ metagenomes. While microbial or-
ganisms varied among subjects as de-
scribed above, metabolic pathways
necessary for human-associated microbial
life were consistently present, forming a
functional ‘‘core’’ to the microbiome at all
body sites [2,43,53]. Although the path-
ways and processes of this core were
consistent, the particular genes that im-
plemented them again varied. Microbial
sugar utilization, for example, was en-
riched for metabolism of simple sugars in
the oral cavity, complex carbohydrates in
the gut, and glycogen/peptidoglycan deg-
radation in the vaginal microbiome [62].
The healthy microbiome may thus achieve
a consistent balance of function and
metabolism that is maintained in health,
but with fine-grained details personalized
by genetics, early life events, environmen-
tal factors such as diet, and a lifetime of
pharmaceutical and immunological expo-
sures [41].
The Healthy Microbiome
Informs Studies of Disease
Data from individuals without overt
signs of disease serve as an excellent
reference for disease-associated micro-
biome studies, while also providing a
comprehensive baseline for comparison
of Western populations with disparate
geographic, ethnic, and genetic cohorts
[63]. The adoption of uniform sampling,
nucleic acid extraction, sequencing, and
analysis protocols is an important step in
such integration, with some success al-
ready realized in, for example, several
aspects of autoimmune disease. The in-
flammatory bowel diseases have long been
linked to the human gut microbiome [22],
with integration of host genotype, gene
expression, and microbial membership
now suggesting mediation of specific
host-microbial interactions by human gene
products as well as by host environment
[64,65]. Bacteria are of course not the only
mediators of dysbiotic disease, and meta-
genomic approaches can also be used to
identify potential viral etiologies (e.g., in
pediatric fever of undefined origin [66]).
Likewise the ‘‘healthy’’ microbiome pro-
Figure 2. HMP consortium activities as a model for microbiome data generation and analyses. (A) Initiatives within the HMP coordinated
to isolate samples, generate data, perform analysis, and publish results. Technology development was employed to develop novel bacterial culture and
DNA isolation techniques. Ethical Legal and Social Implications (ELSI) work anticipated societal implications and guided policies associated with human
subject microbiomes. Clinical sites were collected samples from large cohorts of healthy individuals, with nucleotide sequence information derived at
four sequencing centers at the Baylor College of Medicine (BCM), the Broad Institute, the J. Craig Venter Institute (JCVI), and the Washington University
Genome Institute (WUGI). Additional demonstration projects assessed primarily microbiome alterations related to disease. In addition to analysis
throughout the HMP consortium, computational tools were funded to address, for example, genome assembly, microbial ecology, and statistical
modeling. A data analysis and coordination center provided a portal to all data generated. (B) Overview of the analysis approaches that were the
ultimate product of the HMP consortium, corresponding to data products and protocols available at http://hmpdacc.org.
doi:10.1371/journal.pbio.1001377.g002
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with disease-related studies, but for broad-
er populations such as a recent compari-
son using HMP protocols among a cohort
of pregnant women [67]. The normal
variation of the microbiome within
healthy states and its potential misregula-
tion in disease is thus being pursued in
earnest, as related laboratory and compu-
tational methods continue to be adapted
to better characterize the impact of
bacteria, archaea, viruses, and fungi
throughout human body habitats.
The HMP has thus greatly advanced
our knowledge of the microbes in a
healthy adult reference population, and
provided much-needed infrastructure in
terms of reference genomes, laboratory
protocols, computational methods, and
ELSI considerations [1,2] to help enable
a vast range of studies that will likely find
associations between human-associated
microbial communities and disease. The
next steps will be to discover which of
these microbial community changes result
from disease and which cause it, to
understand how healthy variation relates
to variation within the context of different
disorders, and to use a combination of
laboratory and computational techniques
to begin unraveling causal mechanisms on
levels ranging from the molecular to the
societal. In particular, the study of indi-
viduals of all ages and across cultures,
together with prospective longitudinal
studies and careful work in in vitro and
animal models, will be critical to develop-
ing both the science and the technology
that will allow us to alter our microbial
genomes, far easier to alter than the host
genome within each of our ‘‘human’’ cells,
in order to maintain and improve health.
Acknowledgments
The authors would like to thank Jean McEwen
and Lita Proctor for consultation to confirm the
accuracy of Human Microbiome Project pro-
gram elements.
References
1. The Human Micorbiome Project Consortium
(2012) A framework for human microbiome
research. Nature 486: 215–221.
2. The Human Micorbiome Project Consortium
(2012) Structure, function and diversity of the
healthy human microbiome. Nature 486: 207–
214.
3. Relman DA, Falkow S (2001) The meaning and
impact of the human genome sequence for
microbiology. Trends Microbiol 9: 206–208.
4. Davies J (2001) In a map for human life, count the
microbes, too. Science 291: 2316.
5. Stahl DA, Lane DJ, Olsen GJ, Pace NR (1984)
Analysis of hydrothermal vent-associated symbi-
onts by ribosomal RNA sequences. Science 224:
409–411.
6. Pace NR (1997) A molecular view of microbial
diversity and the biosphere. Science 276: 734–
740.
7. Handelsman J (2004) Metagenomics: application
of genomics to uncultured microorganisms. Mi-
crobiol Mol Biol Rev 68: 669–685.
8 .S t e i nJ L ,M a r s hT L ,W uK Y ,S h i z u y aH ,
DeLong EF (1996) Characterization of unculti-
vated prokaryotes: isolation and analysis of a 40-
kilobase-pair genome fragment from a planktonic
marine archaeon. J Bacteriol 178: 591–599.
9. Handelsman J, Rondon MR, Brady SF, Clardy J,
Goodman RM (1998) Molecular biological access
to the chemistry of unknown soil microbes: a new
frontier for natural products. Chem Biol 5: R245–
R249.
10. DeLong EF (2002) Microbial population geno-
mics and ecology. Curr Opin Microbiol 5: 520–
524.
11. National Research Council (US) Committee on
Metagenomics (2007) The new science of meta-
genomics.
12. Kroes I, Lepp PW, Relman DA (1999) Bacterial
diversity within the human subgingival crevice.
Proc Natl Acad Sci U S A 96: 14547–14552.
13. Ley RE, Backhed F, Turnbaugh P, Lozupone
CA, Knight RD, et al. (2005) Obesity alters gut
microbial ecology. Proc Natl Acad Sci U S A 102:
11070–11075.
14. Gill SR, Pop M, Deboy RT, Eckburg PB,
Turnbaugh PJ, et al. (2006) Metagenomic
analysis of the human distal gut microbiome.
Science 312: 1355–1359.
15. Margulies M, Egholm M, Altman WE, Attiya S,
Bader JS, et al. (2005) Genome sequencing in
microfabricated high-density picolitre reactors.
Nature 437: 376–380.
16. McKenna P, Hoffmann C, Minkah N, Aye PP,
Lackner A, et al. (2008) The macaque gut
microbiome in health, lentiviral infection, and
chronic enterocolitis. PLoS Pathog 4: e20.
doi:10.1371/journal.ppat.0040020
17. Fierer N, Hamady M, Lauber CL, Knight R
(2008) The influence of sex, handedness, and
washing on the diversity of hand surface bacteria.
Proc Natl Acad Sci U S A 105: 17994–17999.
18. Lederberg J (2000) Infectious history. Science
288: 287–293.
19. Peterson J, Garges S, Giovanni M, McInnes P,
Wang L, et al. (2009) The NIH Human
Microbiome Project. Genome Res 19: 2317–
2323.
20. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig
SS, et al. (2011) Vaginal microbiome of repro-
ductive-age women. Proc Natl Acad Sci U S A
108 Suppl 1: 4680–4687.
21. Baumgart M, Dogan B, Rishniw M, Weitzman
G, Bosworth B, et al. (2007) Culture independent
analysis of ileal mucosa reveals a selective increase
in invasive Escherichia coli of novel phylogeny
relative to depletion of Clostridiales in Crohn’s
disease involving the ileum. ISME J 1: 403–418.
22. Frank DN, St Amand AL, Feldman RA,
Boedeker EC, Harpaz N, et al. (2007) Molecu-
lar-phylogenetic characterization of microbial
community imbalances in human inflammatory
bowel diseases. Proc Natl Acad Sci U S A 104:
13780–13785.
23. Young VB (2012) The intestinal microbiota in
health and disease. Curr Opin Gastroenterol 28:
63–69.
24. Ursell LK, Clemente JC, Rideout JR, Gevers D,
Caporaso JG, et al. (2012) The interpersonal and
intrapersonal diversity of human-associated mi-
crobiota in key body sites. J Allergy Clin Immunol
129: 1204–1208.
25. Nelson KE, Weinstock GM, Highlander SK,
Worley KC, Creasy HH, et al. (2010) A catalog of
reference genomes from the human microbiome.
Science 328: 994–999.
26. McGuire AL, Colgrove J, Whitney SN, Diaz CM,
Bustillos D, et al. (2008) Ethical, legal, and social
considerations in conducting the Human Micro-
biome Project. Genome Res 18: 1861–1864.
27. Fierer N, Lauber CL, Zhou N, McDonald D,
Costello EK, et al. (2010) Forensic identification
using skin bacterial communities. Proc Natl Acad
Sci U S A 107: 6477–6481.
28. Knight R, Jansson J, Field D, Fierer N, Desai N,
et al. (2012) Unlocking the potential of metage-
nomics through replicated experimental design.
Nat Biotechnol 30: 513–520.
29. Kuczynski J, Lauber CL, Walters WA, Parfrey
LW, Clemente JC, et al. (2012) Experimental and
analytical tools for studying the human micro-
biome. Nat Rev Genet 13: 47–58.
30. Fitzner K, Heckinger E (2010) Sample size
calculation and power analysis: a quick review.
Diabetes Educ 36: 701–707.
31. Bacchetti P (2010) Current sample size conven-
tions: flaws, harms, and alternatives. BMC
Medicine 8: 17.
32. Jumpstart Consortium Human Microbiome Proj-
ect Data Generation Working Group (2012)
Evaluation of 16S rDNA-based community profil-
ing for human microbiome research. PLoS ONE
7: e39315. doi:10.1371/journal.pone.0039315
33. Schloss PD, Gevers D, Westcott SL (2011)
Reducing the effects of PCR amplification and
sequencing artifacts on 16S rRNA-based studies.
PLoS ONE 6: e27310. doi:10.1371/journal.-
pone.0027310
34. McDonald D, Price MN, Goodrich J, Nawrocki
EP, DeSantis TZ, et al. (2012) An improved
Greengenes taxonomy with explicit ranks for
ecological and evolutionary analyses of bacteria
and archaea. ISME J 6: 610–618.
35. Kunin V, Copeland A, Lapidus A, Mavromatis
K, Hugenholtz P (2008) A bioinformatician’s
guide to metagenomics. Microbiol Mol Biol Rev
72: 557–578, Table of Contents.
36. Hamady M, Knight R (2009) Microbial commu-
nity profiling for human microbiome projects:
tools, techniques, and challenges. Genome Res
19: 1141–1152.
37. Wooley JC, Godzik A, Friedberg I (2010) A
primer on metagenomics. PLoS Comput Biol 6:
e1000667. doi:10.1371/journal.pcbi.1000667
38. Friedman J, Alm E (2012) Inferring correlation
networks from genomic survey data. PLoS
Comput Biol. In press.
39. Faust K, Sathirapongsasuti JF, Izard J, Segata N,
Gevers D, et al. (2012) Microbial co-occurrence
relationships in the human microbiome. PLoS
Comput Biol 8: e1002606. doi:10.1371/journal.-
pcbi.1002606
40. Koren S, Treangen TJ, Pop M (2011) Bambus 2:
scaffolding metagenomes. Bioinformatics 27:
2964–2971.
41. Rho M, Wu YW, Tang H, Doak TG, Ye Y
(2012) Diverse CRISPRs evolving in human
microbiomes. PLoS Genet 8: e1002441.
doi:10.1371/journal.pgen.1002441
42. Martin J, Sykes S, Young S, Kota K, Sanka R, et
al. (2012) Optimizing read mapping to reference
genomes to determine composition and species
prevalence in microbial communities. PLoS ONE
7: e36427. doi:10.1371/journal.pone.0036427
43. Abubucker S, Segata N, Goll J, Schubert AM,
Izard J, et al. (2012) Metabolic reconstruction for
metagenomic data and its application to the
human microbiome. PLoS Computl Biol 8:
e1002358. doi:10.1371/journal.pcbi.1002358
44. Segata N, Waldron L, Ballarini A, Narasimhan
V, Jousson O, et al. (2012) Efficient metagenomic
microbial community profiling using unique
clade-specific marker genes. Nat Methods. Epub
PLOS Biology | www.plosbiology.org 4 August 2012 | Volume 10 | Issue 8 | e1001377ahead of print 10 June 2012. doi:10.1038/
nmeth.2066
45. Liu B, Gibbons T, Ghodsi M, Treangen T, Pop
M (2011) Accurate and fast estimation of
taxonomic profiles from metagenomic shotgun
sequences. BMC Genomics 12 Suppl 2: S4.
46. Gonzalez A, Stombaugh J, Lauber CL, Fierer N,
Knight R (2012) SitePainter: a tool for exploring
biogeographical patterns. Bioinformatics 28: 436–
438.
47. Markowitz VM, Chen IM, Palaniappan K, Chu K,
SzetoE,etal.(2012) IMG:theIntegratedMicrobial
Genomes database and comparative analysis sys-
tem. Nucleic Acids Res 40: D115–D122.
48. Goll J, Thiagarajan M, Abubucker S, Hutten-
hower C, Yooseph S, Methe ´ BA (2012) A case
study for large-scale human microbiome analysis
using JCVI’s metagenomics reports (METAREP).
PLoS ONE 7: e29044. doi:10.1371/journal.pone.
0029044
49. Meyer F, Paarmann D, D’Souza M, Olson R,
Glass EM, et al. (2008) The metagenomics RAST
server - a public resource for the automatic
phylogenetic and functional analysis of metagen-
omes. BMC Bioinformatics 9: 386.
50. Turnbaugh PJ, Ley RE, Hamady M, Fraser-
Liggett CM, Knight R, et al. (2007) The human
microbiome project. Nature 449: 804–810.
51. Shade A, Handelsman J (2012) Beyond the Venn
diagram: the hunt for a core microbiome.
Environmental Microbiology 14: 4–12.
52. Tap J, Mondot S, Levenez F, Pelletier E, Caron
C, et al. (2009) Towards the human intestinal
microbiota phylogenetic core. Environmental
Microbiology 11: 2574–2584.
53. Turnbaugh PJ, Hamady M, Yatsunenko T,
Cantarel BL, Duncan A, et al. (2009) A core
gut microbiome in obese and lean twins. Nature
457: 480–484.
54. Grice EA, Kong HH, Renaud G, Young AC,
Bouffard GG, et al. (2008) A diversity profile of
the human skin microbiota. Genome Res 18:
1043–1050.
55. Grice EA, Kong HH, Conlan S, Deming CB,
Davis J, et al. (2009) Topographical and temporal
diversity of the human skin microbiome. Science
324: 1190–1192.
56. Costello EK, Lauber CL, Hamady M, Fierer N,
Gordon JI, et al. (2009) Bacterial community
variation in human body habitats across space
and time. Science 326: 1694–1697.
57. Zaura E, Keijser BJ, Huse SM, Crielaard W
(2009) Defining the healthy ‘‘core microbiome’’ of
oral microbial communities. BMC Microbiology
9: 259.
58. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS,
et al. (2010) A human gut microbial gene
catalogue established by metagenomic sequenc-
ing. Nature 464: 59–65.
59. Huse S, Ye Y, Zhou Y, Fodor AA (2012) A core
human microbiome as viewed through 16S rRNA
sequences clusters. PLoS ONE 7: e34242.
doi:10.1371/journal.pone.0034242
60. Li K, Bihan M, Yooseph S, Methe ´ BA (2012)
Analyses of the microbial diversity across the
human microbiome. PLoS ONE 7: e32118.
doi:10.1371/journal.pone.0032118
61. Arumugam M, Raes J, Pelletier E, Le Paslier D,
Yamada T, et al. (2011) Enterotypes of the
human gut microbiome. Nature 473:174–180.
62. Cantarel BL, Lombard V, Henrissat B (2012)
Complex carbohydrate utilization by the healthy
human microbiome. PLoS ONE 7: e28742.
doi:10.1371/journal.pone.0028742
63. Yatsunenko T, Rey FE, Manary MJ, Trehan I,
Dominguez-Bello MG, et al. (2012) Human gut
microbiome viewed across age and geography.
Nature 486: 222–227.
64. Zhang T, Desimone RA, Jiao X, Rohlf FJ, Zhu
W, et al. (2012) Host genes related to paneth cells
and xenobiotic metabolism are associated with
shifts in human ileum-associated microbial com-
position. PLoS ONE 7: e30044. doi:10.1371/
journal.pone.0030044
65. Li E, Hamm CM, Gulati AS, Sartor RB, Chen H,
et al. (2012) Inflammatory bowel diseases pheno-
type, C. difficile and NOD2 genotype are associ-
ated with shifts in human ileum associated
microbial composition. PLoS ONE 7: e26284.
doi:10.1371/journal.pone.0026284
66. Wylie KM, Truty RM, Sharpton TJ, Mihinduku-
lasuriya KA, Zhou Y, et al. (2012) Novel bacterial
taxa in the human microbiome. PLoS ONE 7:
e35294. doi:10.1371/journal.pone.0035294
67. Aagaard K, Riehle K, Ma J, Segata N, Mistretta
TA, et al. (2012) A metagenomic approach to
characterization of the vaginal microbiome sig-
nature in pregnancy. PLoS ONE 7: e36466.
doi:10.1371/journal.pone.0036466
68. DeLong EF, Preston CM, Mincer T, Rich V,
Hallam SJ, et al. (2006) Community genomics
among stratified microbial assemblages in the
ocean’s interior. Science 311: 496–503.
69. Sogin ML, Morrison HG, Huber JA, Mark
Welch D, Huse SM, et al. (2006) Microbial
diversity in the deep sea and the underexplored
‘‘rare biosphere’’. Proc Natl Acad Sci U S A 103:
12115–12120.
70. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini
V, Mardis ER, et al. (2006) An obesity-associated
gut microbiome with increased capacity for
energy harvest. Nature 444: 1027–1031.
71. Nakamura S, Maeda N, Miron IM, Yoh M,
Izutsu K, et al. (2008) Metagenomic diagnosis of
bacterial infections. Emerg Infect Dis 14: 1784–
1786.
72. Gilbert JA, Field D, Swift P, Newbold L, Oliver
A, et al. (2009) The seasonal structure of
microbial communities in the Western English
Channel. Environmental Microbiology 11: 3132–
3139.
73. Hess M, Sczyrba A, Egan R, Kim TW,
Chokhawala H, et al. (2011) Metagenomic
discovery of biomass-degrading genes and
genomes from cow rumen. Science 331: 463–
467.
74. Yilmaz P, Kottmann R, Field D, Knight R,
Cole JR, et al. (2011) Minimum information
about a marker gene sequence (MIMARKS)
and minimum information about any (x) se-
quence (MIxS) specifications. Nat Biotechnol
29: 415–420.
PLOS Biology | www.plosbiology.org 5 August 2012 | Volume 10 | Issue 8 | e1001377